PAK6 and prostate carcinoma: Additional analyses revealed that miR-23a directly targeted the p21-activated kinase 6 (PAK6) gene to suppress the phosphorylation of LIM kinase 1 (LIMK1), resulting in cytoskeletal reorganization, and ultimately, the inhibition of prostate cancer cell invasion and metastasis.